BA
ANTH

BlackRock Advisors’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

BlackRock Advisors’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$12K Hold
2,227
– – ﹤0.01% 3550
2016
Q3 		$56K Buy
2,227
+33
+2% +$832 ﹤0.01% 3216
2016
Q2 		$54K Hold
2,194
– – ﹤0.01% 3211
2016
Q1 		$64K Buy
2,194
+232
+12% +$6.29K ﹤0.01% 3099
2015
Q4 		$73K Sell
1,962
-1,092
-36% -$48.2K ﹤0.01% 3062
2015
Q3 		$149K Buy
3,054
+380
+14% +$26.6K ﹤0.01% 2889
2015
Q2 		$184K Buy
+2,674
New +$124K ﹤0.01% 2836
2014
Q3 		– Sell
-790
Closed -$21K – 3751
2014
Q2 		$21K Hold
790
– – ﹤0.01% 3442
2014
Q1 		$21K Hold
790
– – ﹤0.01% 3410
2013
Q4 		$19K Buy
790
+345
+78% +$8.89K ﹤0.01% 3403
2013
Q3 		$14K Buy
445
+290
+187% +$8.99K ﹤0.01% 3396
2013
Q2 		$5K Buy
+155
New +$5.78K ﹤0.01% 3523

Other funds holding ANTH

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock Advisors's ANTH Position: Q4 2016 in Review

BlackRock Advisors held its Anthera Pharmaceuticals, Inc. (ANTH) position steady in Q4 2016 at 2,227 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #3550.

BlackRock Advisors first reported a position in ANTH in Q2 2013 and has held it in 12 quarters since. The position peaked at $184K in Q2 2015. 72 funds tracked by Wall St. Rank hold ANTH as of Q4 2016.

  • BlackRock Advisors held 2,227 shares of Anthera Pharmaceuticals, Inc. worth $12K as of Q4 2016.
  • BlackRock Advisors left its Anthera Pharmaceuticals, Inc. share count unchanged in Q4 2016.
  • Anthera Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3550 holding.
  • BlackRock Advisors first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2013 and has held it in 12 quarters since.
  • BlackRock Advisors's Anthera Pharmaceuticals, Inc. position peaked at $184K in Q2 2015.
  • 72 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.